Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind Randomized, Placebo-controlled, Crossover Study of Single Doses of OROS Methylphenidate Hydrochloride (CONCERTA) and Long-acting Methylphenidate Hydrochloride (RITALIN LA) in Healthy Adults

NCT00302354 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00302354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00302354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind Randomized, Placebo-controlled, Crossover Study of Single Doses of OROS Methylphenidate Hydrochloride (CONCERTA) and Long-acting Methylphenidate Hydrochloride (RITALIN LA) in Healthy Adults
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2004
Completion date
September 30, 2005
Enrollment
50
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers